Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency

2009 ◽  
Vol 30 (2) ◽  
pp. 321-329 ◽  
Author(s):  
Melvin Berger ◽  
Paul J. Pinciaro ◽  
Arthur Althaus ◽  
Mark Ballow ◽  
Akhilesh Chouksey ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Primary Immunodeficiency ◽  
High Purity ◽  
Human Intravenous Immunoglobulin

scholarly journals Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency

2020 ◽  
Vol 34 ◽  
pp. 205873842094300
Author(s):  
Silvia Ricci ◽  
Francesca Lippi ◽  
Clementina Canessa ◽  
Chiara Guarnieri ◽  
Roberta Macchia ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Primary Immunodeficiency ◽  
Pediatric Patients ◽  
Pediatric Population ◽  
Ivig Treatment ◽  
Severe Infections ◽  
Immunoglobulin Treatment ◽  
Human Intravenous Immunoglobulin ◽  
Selection Of

Patients affected by primary immunodeficiencies are characterized for high susceptibility for severe infections. Our data demonstrate Kedrion 5% intravenous immunoglobulin G (IVIg) treatment effective and safe as replacement therapy for children and adolescents affected by primary immunodeficiency. The particularities of our study are the selection of a long period of follow-up (71 patient-years of follow-up), and to the best of our knowledge, our study is one of few that assesses the safety and efficacy of intravenous immunoglobulin treatment of primary immunodeficiency specifically in a pediatric population.

scholarly journals Intravenous Immunoglobulin Replacement Therapy in Children with Primary Immunodeficiency Diseases: A Nurse's Guide

2018 ◽  
Vol 2 (2) ◽  
pp. 149-156
Author(s):  
Ana Marija Hošnjak ◽  
Snježana Čukljek ◽  
Sanja Ledinski Fičko ◽  
Martina Smrekar ◽  
Nikolina Veriga ◽  
...  
Keyword(s):  
Replacement Therapy ◽  
Intravenous Immunoglobulin ◽  
Primary Immunodeficiency ◽  
Primary Immunodeficiency Diseases ◽  
Immunodeficiency Diseases ◽  
Immunoglobulin Replacement Therapy ◽  
Immunoglobulin Replacement
Sign in / Sign up

Export Citation Format

Share Document